Cefmetazole sodium is a semi-synthetic cephamycin antibiotic with broad-spectrum antibacterial activity, exhibiting antimicrobial properties similar to second-generation cephalosporins. It is used for the treatment of infections caused by susceptible strains of *Staphylococcus aureus*, *Escherichia coli*, *Klebsiella pneumoniae*, *Proteus* spp., *Morganella morganii*, *Providencia* spp., *Peptostreptococcus* spp., *Bacteroides* spp., and *Prevotella* spp. (excluding *Bilophila wadsworthia*), including:
1. Sepsis;
2. Acute bronchitis, pneumonia, lung abscess, empyema, and secondary infections in chronic respiratory diseases;
3. Cystitis and pyelonephritis;
4. Peritonitis;
5. Cholecystitis and cholangitis;
6. Bartholinitis, intrauterine infections, adnexitis, and parametritis;
7. Perimandibular cellulitis and osteomyelitis of the jaw.
Cefmetazole sodium is also used in the management of gynecological, intra-abdominal, urinary tract, respiratory, and skin and soft tissue infections.